Alerts will be sent to your verified email
Verify EmailSANDUPHQ
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Sandu Pharmaceuticals Limited, incorporated in India in 1985, manufactures and trades Ayurvedic medicines under the brand name SANDU with a manufacturing plant in Goa.
Sandu Pharmaceutical major competitors are Goldline Pharma., Roopa Industries, Lasa Supergenerics, Vista Pharmaceutical, Rajnish Wellness, Mangalam Drugs&Org., Deccan Health Care.
Market Cap of Sandu Pharmaceutical is ₹40 Crs.
While the median market cap of its peers are ₹42 Crs.
Sandu Pharmaceutical seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.